|
1
|
Liu H, Han L, Liu Z and Gao N: Long
noncoding RNA MNX1-AS1 contributes to lung cancer progression
through the miR-527/BRF2 pathway. J Cell Physiol. 234:13843–13850.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang L, Qu J, Zhou L, Liao F and Wang J:
MicroRNA-373 Inhibits Cell Proliferation and Invasion via Targeting
BRF2 in Human Non-small Cell Lung Cancer A549 Cell Line. Cancer Res
Treat. 50:936–949. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lu J and Han B: Liquid Biopsy Promotes
Non-Small Cell Lung Cancer Precision Therapy. Technol Cancer Res
Treat. 17:15330338188018092018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Collins LG, Haines C, Perkel R and Enck
RE: Lung cancer: Diagnosis and management. Am Fam Physician.
75:56–63. 2007.PubMed/NCBI
|
|
5
|
Tian Y, Wang C and Lu M: BRF2 as a
promising indicator for radical lymph-node dissection surgery in
patients with cN0 squamous cell carcinoma of the middle thoracic
esophagus. Surg Today. 49:158–169. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Verma N, Hurlburt AM, Wolfe A, Kim MK,
Kang YS, Kang JJ and Stumph WE: Bdp1 interacts with SNAPc bound to
a U6, but not U1, snRNA gene promoter element to establish a stable
protein-DNA complex. FEBS Lett. 592:2489–2498. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McQueen C, Hughes GL and Pownall ME:
Skeletal muscle differentiation drives a dramatic downregulation of
RNA polymerase III activity and differential expression of Polr3g
isoforms. Dev Biol. 454:74–84. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Geiduschek EP and Kassavetis GA: The RNA
polymerase III transcription apparatus. J Mol Biol. 310:1–26. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Saxena A, Ma B, Schramm L and Hernandez N:
Structure-function analysis of the human TFIIB-related factor II
protein reveals an essential role for the C-terminal domain in RNA
polymerase III transcription. Mol Cell Biol. 25:9406–9418. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song W, Filonov GS, Kim H, Hirsch M, Li X,
Moon JD and Jaffrey SR: Imaging RNA polymerase III transcription
using a photostable RNA-fluorophore complex. Nat Chem Biol.
13:1187–1194. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Scott PH, Cairns CA, Sutcliffe JE,
Alzuherri HM, McLees A, Winter AG and White RJ: Regulation of RNA
polymerase III transcription during cell cycle entry. J Biol Chem.
276:1005–1014. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lei J, Chen S and Zhong S: Abnormal
expression of TFIIIB subunits and RNA Pol III genes is associated
with hepatocellular carcinoma. Liver Res. 1:112–120. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
White RJ: RNA polymerase III transcription
- a battleground for tumour suppressors and oncogenes. Eur J
Cancer. 40:21–27. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cabarcas S, Jacob J, Veras I and Schramm
L: Differential expression of the TFIIIB subunits Brf1 and Brf2 in
cancer cells. BMC Mol Biol. 9:742008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Johnson SA, Dubeau L, Kawalek M, Dervan A,
Schönthal AH, Dang CV and Johnson DL: Increased expression of
TATA-binding protein, the central transcription factor, can
contribute to oncogenesis. Mol Cell Biol. 23:3043–3051. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Srihari S, Kalimutho M, Lal S, Singla J,
Patel D, Simpson PT, Khanna KK and Ragan MA: Understanding the
functional impact of copy number alterations in breast cancer using
a network modeling approach. Mol Biosyst. 12:963–972. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ng CK, Martelotto LG, Gauthier A, Wen HC,
Piscuoglio S, Lim RS, Cowell CF, Wilkerson PM, Wai P, Rodrigues DN,
et al: Intra-tumor genetic heterogeneity and alternative driver
genetic alterations in breast cancers with heterogeneous HER2 gene
amplification. Genome Biol. 16:1072015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lockwood WW, Chari R, Coe BP, Thu KL,
Garnis C, Malloff CA, Campbell J, Williams AC, Hwang D, Zhu CQ, et
al: Integrative genomic analyses identify BRF2 as a novel
lineage-specific oncogene in lung squamous cell carcinoma. PLoS
Med. 7:e10003152010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Almanza A, Carlesso A, Chintha C,
Creedican S, Doultsinos D, Leuzzi B, Luís A, McCarthy N,
Montibeller L, More S, et al: Endoplasmic reticulum stress
signalling - from basic mechanisms to clinical applications. FEBS
J. 286:241–278. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Garcia MJ, Pole JC, Chin SF, Teschendorff
A, Naderi A, Ozdag H, Vias M, Kranjac T, Subkhankulova T, Paish C,
et al: A 1 Mb minimal amplicon at 8p11-12 in breast cancer
identifies new candidate oncogenes. Oncogene. 24:5235–5245. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guo Q, Li H, Liu J, Xu L, Yang L, Sun Z
and Zhou B: Tunicamycin aggravates endoplasmic reticulum stress and
airway inflammation via PERK-ATF4-CHOP signaling in a murine model
of neutrophilic asthma. J Asthma. 54:125–133. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jin J, Zhao L, Zou W, Shen W, Zhang H and
He Q: Activation of Cyclooxygenase-2 by ATF4 During Endoplasmic
Reticulum Stress Regulates Kidney Podocyte Autophagy Induced by
Lupus Nephritis. Cell Physiol Biochem. 48:753–764. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thawani R, McLane M, Beig N, Ghose S,
Prasanna P, Velcheti V and Madabhushi A: Radiomics and
radiogenomics in lung cancer: A review for the clinician. Lung
Cancer. 115:34–41. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hirsch FR, Scagliotti GV, Mulshine JL,
Kwon R, Curran WJ Jr, Wu YL and Paz-Ares L: Lung cancer: Current
therapies and new targeted treatments. Lancet. 389:299–311. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hashemi ZS, Khalili S, Forouzandeh
Moghadam M and Sadroddiny E: Lung cancer and miRNAs: A possible
remedy for anti-metastatic, therapeutic and diagnostic
applications. Expert Rev Respir Med. 11:147–157. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Melchor L, Garcia MJ, Honrado E, Pole JC,
Alvarez S, Edwards PA, Caldas C, Brenton JD and Benítez J: Genomic
analysis of the 8p11-12 amplicon in familial breast cancer. Int J
Cancer. 120:714–717. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cabarcas S and Schramm L: RNA polymerase
III transcription in cancer: The BRF2 connection. Mol Cancer.
10:472011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rosenwald IB: The role of translation in
neoplastic transformation from a pathologist's point of view.
Oncogene. 23:3230–3247. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang WB, Zhang WP, Shi JL and Wang JW:
miR-4299 suppresses non-small cell lung cancer cell proliferation,
migration and invasion through modulating PTEN/AKT/PI3K pathway.
Eur Rev Med Pharmacol Sci. 22:3408–3414. 2018.PubMed/NCBI
|
|
32
|
Khodapasand E, Jafarzadeh N, Farrokhi F,
Kamalidehghan B and Houshmand M: Is Bax/Bcl-2 ratio considered as a
prognostic marker with age and tumor location in colorectal cancer?
Iran Biomed J. 19:69–75. 2015.PubMed/NCBI
|
|
33
|
Sigismund S, Avanzato D and Lanzetti L:
Emerging functions of the EGFR in cancer. Mol Oncol. 12:3–20. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Farmakovskaya M, Khromova N, Rybko V,
Dugina V, Kopnin B and Kopnin P: E-Cadherin repression increases
amount of cancer stem cells in human A549 lung adenocarcinoma and
stimulates tumor growth. Cell Cycle. 15:1084–1092. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Quintanal-Villalonga Á, Ojeda-Márquez L,
Marrugal Á, Yagüe P, Ponce-Aix S, Salinas A, Carnero A, Ferrer I,
Molina-Pinelo S and Paz-Ares L: The FGFR4-388arg Variant Promotes
Lung Cancer Progression by N-Cadherin Induction. Sci Rep.
8:23942018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang K, Li XY, Wang ZM, Han ZF and Zhao
YH: miR-22 inhibits lung cancer cell EMT and invasion through
targeting Snail. Eur Rev Med Pharmacol Sci. 21:3598–3604.
2017.PubMed/NCBI
|
|
37
|
Tian Y, Lu M, Yue W, Li L, Li S, Gao C, Si
L, Qi L, Hu W and Tian H: TFIIB-related factor 2 is associated with
poor prognosis of nonsmall cell lung cancer patients through
promoting tumor epithelial-mesenchymal transition. BioMed Res Int.
2014:5307862014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gouge J, Satia K, Guthertz N, Widya M,
Thompson AJ, Cousin P, Dergai O, Hernandez N and Vannini A: Redox
Signaling by the RNA Polymerase III TFIIB-Related Factor Brf2.
Cell. 163:1375–1387. 2015. View Article : Google Scholar : PubMed/NCBI
|
